Market pulse › Summit Therapeutics
Summit Therapeutics
Today1 story · 1 articles
Net tone● ±0% today
Market check
Developing0 storylines
129 Sept
030 Sept
11 Oct
Legal● mixedWhy is Liquidia stock plunging? Yutrepia patent case explainedLiquidia shares plunged nearly 50% after a US court ruled against the company in a patent disputePharma and healthcare
Deal● mixedAstraZeneca to Invest $2 Billion in Summit Therapeutics, Collaborate on Cancer DrugsAstraZeneca plans to invest $2 billion in Summit TherapeuticsPharma and healthcareAstraZeneca